Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB11880InvestigationalSmall molecule
Acridine Carboxamide has been used in trials studying the treatment of Lung Cancer and Brain and Central Nervous System Tumors.
- Mechanism
- Curator reviewed
Pharmacologically active on DNA topoisomerase 1 and DNA topoisomerase 2
- Formula / weight
- C18H19N3O · 293.37 g/mol (avg)
- Also known as
- 4-ACRIDINECARBOXAMIDE, N-(2-(DIMETHYLAMINO)ETHYL)- · DACA · N-(2-(DIMETHYLAMINO)ETHYL)ACRIDINE-4-CARBOXAMIDE
- Code names
- NSC-601316 · XR-5000
Resolves to
Structure
InChIKey
XBGNERSKEKDZDS-UHFFFAOYSA-NSMILESCN(C)CCNC(=O)C1=C2N=C3C=CC=CC3=CC2=CC=C1Targets
What you can answer from here — as of July 07, 2026
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Acridine Carboxamide, and which of those have an active Phase 3 trial?